A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Mimedx Group, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 8,000 shares of MDXG stock, worth $74,160. This represents 0.0% of its overall portfolio holdings.

Number of Shares
8,000
Previous 34,600 76.88%
Holding current value
$74,160
Previous $239,000 80.33%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$5.65 - $7.76 $2.29 Million - $3.15 Million
405,648 Added 1005.95%
445,973 $2.64 Million
Q2 2024

Aug 14, 2024

BUY
$6.16 - $8.08 $248,402 - $325,826
40,325 New
40,325 $279,000
Q4 2023

Feb 14, 2024

SELL
$5.7 - $9.14 $665,144 - $1.07 Million
-116,692 Reduced 99.38%
724 $6,000
Q3 2023

Nov 14, 2023

SELL
$6.35 - $8.16 $565,492 - $726,680
-89,054 Reduced 43.13%
117,416 $855,000
Q2 2023

Aug 14, 2023

SELL
$3.14 - $6.61 $338,400 - $712,366
-107,771 Reduced 34.3%
206,470 $1.36 Million
Q1 2023

May 15, 2023

BUY
$2.97 - $4.81 $465,820 - $754,410
156,842 Added 99.65%
314,241 $1.07 Million
Q4 2022

Feb 14, 2023

BUY
$2.63 - $3.45 $269,062 - $352,952
102,305 Added 185.69%
157,399 $437,000
Q3 2022

Nov 14, 2022

SELL
$2.71 - $4.22 $136,047 - $211,852
-50,202 Reduced 47.68%
55,094 $158,000
Q2 2022

Aug 15, 2022

SELL
$3.17 - $5.0 $792,103 - $1.25 Million
-249,875 Reduced 70.35%
105,296 $365,000
Q1 2022

May 16, 2022

BUY
$4.27 - $6.27 $354,721 - $520,867
83,073 Added 30.53%
355,171 $1.67 Million
Q4 2021

Feb 14, 2022

BUY
$5.7 - $8.48 $1.11 Million - $1.65 Million
194,217 Added 249.38%
272,098 $1.64 Million
Q3 2021

Nov 15, 2021

BUY
$5.52 - $15.83 $353,644 - $1.01 Million
64,066 Added 463.74%
77,881 $472,000
Q2 2021

Aug 16, 2021

SELL
$9.02 - $12.72 $2.68 Million - $3.78 Million
-297,451 Reduced 95.56%
13,815 $172,000
Q1 2021

May 17, 2021

BUY
$8.48 - $11.28 $1.94 Million - $2.58 Million
228,854 Added 277.69%
311,266 $3.21 Million
Q4 2020

Feb 16, 2021

SELL
$5.32 - $10.17 $224,259 - $428,706
-42,154 Reduced 33.84%
82,412 $748,000
Q3 2018

Nov 13, 2018

BUY
$3.22 - $6.33 $168,470 - $331,185
52,320 Added 72.42%
124,566 $0
Q4 2017

Feb 09, 2018

SELL
$10.87 - $13.9 $3.31 Million - $4.23 Million
-304,057 Reduced 80.8%
72,246 $911,000
Q3 2017

Nov 09, 2017

BUY
$11.86 - $17.34 $4.46 Million - $6.53 Million
376,303
376,303 $4.47 Million

Others Institutions Holding MDXG

About MIMEDX GROUP, INC.


  • Ticker MDXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 113,609,000
  • Market Cap $1.05B
  • Description
  • MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary pr...
More about MDXG
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.